WASHINGTON, DC – The U.S. Department of Justice has charged Indian chemical manufacturer Vasudha Pharma Chem Limited (VPC) ...

CRISPR, The New Gold Standard?Understanding The Rise Of Genetic Engineering In India – Part 2. Legal News and Analysis - ...

An India-based chemical manufacturing firm, Vasudha Pharma Chem Limited, and its high-level employees face charges in a US federal court for illegally importing precursor chemicals used to make ...

On Tuesday, India’s top specialty generics company Sun Pharma announced the acquisition of the US-based Checkpoint for $355 million to enhance its oncology portfolio. Analysts view this ...

Diego Garcia, a remote Indian Ocean island nearly 2,000 miles from the East African coast, boasts clear-blue waters, pristine beaches — and a US-UK military base at the heart of the great-power ...

Vice President JD Vance will travel to India later this month alongside Second Lady Usha Vance, according to three sources familiar with the plans. It marks Vance’s second foreign trip as vice ...

HONG KONG — Six of the world’s 10 most polluted cities are in India, while California has the worst air pollution in North America, a new report shows. New Delhi was the most polluted capital ...

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

This Pharma stock, which deals in the business of manufacture, distribution, and marketing of products related to pharmaceuticals, was up 3 percent after permission to sell Durvalumab in India used ...

The diabetes care landscape in India is set for a major transformation as domestic pharmaceutical companies reportedly prepare to launch low-cost generic versions of Empagliflozin. The move comes ...

Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, following the expiry of its patent. Estimated to significantly cut costs and ...

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of ...